Zinbryta (daclizumab) by Biogen
January 2018
Zinbryta (daclizumab) by Biogen Zinbryta (daclizumab) by Biogen Zinbryta (daclizumab) by Biogen Voluntary withdrawal due to safety concerns, including reports of severe liver damage and immune-related conditions....
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive